中文站
|
Set home
|
Add to Favorites
Home
Overview
ABOUT Sino-Strong
News Center
HSE Policy
Services&Products
API
Medicinal Intermediates
Custom Synthesis
IP Support
Quality System
QA
QC
R&D
R & D
R & D Mission
Contact
Products
API
Intermediates
Dolasetron Mesylate
Rocuronium Bromi Intermediates
Palonosetron Hydrochloride
Fasudil
Solifenacin Succinate
Darifenacin Hydrobromide
Zofenopril Calcium
Arformoterol Tartrate
Mitiglinide Calcium
Moxifloxacin Hydrochloride
Azasetron Hydrochloride
Linezolid intermediate
Argatroban intermediate
Working standard
Custom Synthesis
IP Support
Product Search
News
·
Dolasetron Mesylate GMP Certificat
[2011-12-6]
·
Dolasetron Mesylate Certificat
[2011-8-8]
·
Enterprise Innovation Award
[2011-8-8]
·
CPhI & ICSE China 2011
[2011-5-9]
·
The 66th API China 2011 Chengd
[2010-12-29]
·
The 65th API CHINA & INTERPHEX China, Our booth: 5B266
[2010-8-16]
·
Science and technology award
[2010-5-20]
·
CPhI & ICSE China 2010
[2010-4-1]
·
CPhI Worldwide 2009
[2009-9-1]
·
CPhI & ICSE China 2009
[2009-8-28]
·
Our company get New High-tech Enterprises Certificate
[2009-5-30]
·
Sichuan Earthquake
[2008-9-1]
Home Previous Next Last Page:
1
/1
Page
20
News/Page Go to:
1Page
Copyright ©2007 Sino-Strong All rights reserved
备案号:蜀字备62135657号
Pancuronium Bromide Rocuronium Bromide (S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline Zofenopril calciumDolasetron Mesylate